| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Relmada Therapeutics, Inc. (RLMD) has 7 insiders with recent SEC Form 4 filings, including 9 buys and 7 sells. RLMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.30M | $9.52M | - | |
| COO | 828.0K | $6.06M | - | |
| Other | 828.0K | $6.06M | - | |
| CFO | 800.0K | $5.86M | - | |
| Dir | 164.0K | $1.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2021 | Casamento Charles J71 | Director | Sell | 3,000 | $32.11 | $96,341.70 | -12.0% | |
| Dec 1, 2020 | Casamento Charles J71 | Director | Sell | 3,000 | $35.74 | $107,219.10 | -10.7% | |
| Nov 2, 2020 | Casamento Charles J71 | Director | Sell | 3,000 | $30.29 | $90,863.70 | -5.8% | |
| Oct 1, 2020 | Casamento Charles J71 | Director | Sell | 3,000 | $37.99 | $113,955.60 | -5.4% | |
| Sep 1, 2020 | Casamento Charles J71 | Director | Sell | 3,000 | $34.74 | $104,206.80 | -5.2% | |
| Aug 3, 2020 | Casamento Charles J71 | Director | Sell | 3,000 | $35.74 | $107,213.40 | -8.1% | |
| Jul 1, 2020 | Casamento Charles J71 | Director | Sell | 3,000 | $43.89 | $131,677.20 | -7.5% | |
| Oct 21, 2019 | Shenouda Maged | Director | Buy | 978 | $23.00 | $22,494.00 | +78.2% | |
| Oct 18, 2019 | Kelly Paul Edward53 | Director | Buy | 5,000 | $19.14 | $95,685.00 | +0.6% | |
| May 14, 2019 | Kelly Paul Edward53 | Director | Buy | 100,000 | $1.50 | $150,000.00 | +25.7% |